Patent · US Active

Vasoprotective and cardioprotective antidiabetic therapy

US11911387B2 · kind B2 · utility

0Cited by

166References

3Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas KLEIN · Radolfzell, DE
Andreas DAIBER · Scheeßel, DE
Odd-Erik JOHANSEN · Måløy, NO
Michael Mark · Biberach an der Riß, DE
Sanjaykumar PATEL · Teddington, GB
Hans-Juergen WOERLE · Munich, DE

Key dates

Filing date	Dec 15, 2020
Grant date	Feb 27, 2024
Priority date	—
Expiry date	Jul 1, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to certain DPP-4 inhibitors for treating and/or preventing oxidative stress, vascular stress and/or endothelial dysfunction as well as to the use of such DPP-4 inhibitors in treatment and/or prevention of diabetic or non-diabetic patients, including patient groups at risk of cardiovascular and/or renal disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.